Mild, Moderate and Severe Renal Impairment Study
NCT02219516
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
RDEA3170
Sponsor
Ardea Biosciences, Inc.